Amplify Weight Loss Drug & Treatment ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THNR and other ETFs, options, and stocks.

About THNR

THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. 

Index-Tracked
VettaFi Weight Loss Drug & Treat TR USD
Index-TrackedVettaFi Weight Loss Drug & Treat TR USD
Category
Health
CategoryHealth
Number of holdings
30
Number of holdings30
Inception Date
May 20, 2024
Inception DateMay 20, 2024

What's in this fund

Sectors

As of July 23, 2024
Healthcare90.56%
Industrials4.97%
Basic Materials3.69%
Consumer Defensive0.78%

Top 10 Holdings (71.15% of total assets)

As of July 23, 2024
NameSymbol% Assets
Eli LillyLLY14.22%
Novo NordiskNVO13.01%
AstraZenecaAZN7.20%
Chugai Pharmaceutical Co Ltd4519 (XTKS)5.75%
AmgenAMGN5.53%
Roche Holding AGROG (XSWX)5.50%
PfizerPFE5.30%
Thermo Fisher ScientificTMO4.95%
FUJIFILM Holdings Corp4901 (XTKS)4.93%
MerckMRK4.76%

THNR Key Statistics

AUM
3.15M
AUM3.15M
Price-Earnings ratio
46.20
Price-Earnings ratio46.20
30-Day yield
—
30-Day yield—
Average volume
3.76K
Average volume3.76K
High today
$26.25
High today$26.25
Low today
$26.15
Low today$26.15
Open price
$26.25
Open price$26.25
Volume
899.00
Volume899.00
52 Week high
$27.07
52 Week high$27.07
52 Week low
$24.92
52 Week low$24.92
Expense ratio
0.59
Expense ratio0.59
View Prospectus and Reports

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.